Hy-Vee claims $5 million in losses for non-reimbursed COVID-19 vaccinations

The Hy-Vee grocery chain is suing a Texas billing company over $5 million worth of COVID-19 vaccines that didn’t qualify for reimbursement by the federal government. This Hy-Vee Pharmacy is located at 410 N. Ankeny Blvd. in Ankeny, Iowa. (Photo via Google Earth)
The Hy-Vee grocery chain is suing a Texas billing company over $5 million worth of COVID-19 vaccinations, the cost of which was never reimbursed by the federal government.
Hy-Vee Inc. is suing Omnisys, a Texas limited liability company also known as XiFin Pharmacy Solutions, in U.S. District Court for the Southern District of Iowa.
Hy-Vee, whose food stores typically include full-service pharmacies, alleges that during the COVID-19 pandemic, the nation’s pharmacies were required, by the federal government, to provide vaccinations at no cost to patients in an effort to stem the spread of the virus. The federal government agreed to reimburse those pharmacies for the cost of administering the vaccinations to the uninsured and the underinsured.
Hy-Vee alleges it was eligible to receive $40 per vaccine, and that it administered “hundreds of thousands of COVID vaccinations at no cost to the target patient populations” pursuant to the federal program.
GET THE MORNING HEADLINES.
In March 2022, the federal government announced the reimbursement program would stop accepting claims after April 5, 2022, due to concerns that funding for the program was running out.
According to the lawsuit, Hy-Vee and many other pharmacies contracted with Omnisys to act as a “clearinghouse” for the submission of reimbursement claims to the federal government, and paid Omnisys for each claim that the Texas company processed and submitted.
Hy-Vee claims that while most of its claims were accepted and reimbursed, some were rejected, with Omnisys asserting that the reason for some of those rejections was lack of funding for reimbursement.
Through Freedom of Information Act requests, Hy-Vee now alleges, the company learned directly from the federal government that the reimbursement program did not run out of money to pay any eligible claims submitted before the April 5, 2022, deadline. In addition, the information obtained by Hy-Vee indicated that some claims were rejected after being submitted after the deadline.
Hy-Vee’s lawsuit suggests Omnisys is to blame for rejected claims the grocery chair had turned over for processing – although, because Hy-Vee’s court petition is heavily redacted, the precise nature of Omnisys’ alleged failures isn’t clear.
For example, the publicly filed lawsuit states: “Despite receiving claims from Hy-Vee for processing, Omnisys failed to [redacted] … Omnisys also failed to [redacted] … Omnisys failed to [redacted], resulting in millions of dollars of losses to Hy-Vee … On June 23, 2022, Omnisys admitted that it timely received over 100,000 claims from Hy-Vee but failed [redacted].”
Hy-Vee alleges the redacted information, if made public, would violate the terms of confidentiality provisions written into its contract with Omnisys.
The specific allegations concerning Omnisys’ alleged failures, while redacted from public view, fall within two separate categories the lawsuit labels as “late claims” and “unsubmitted claims.” Hy-Vee alleges its own investigation of the matter has “uncovered that Hy-Vee timely submitted more than 150,000 claims to Omnisys that were not reimbursed” due to the Texas company’s alleged failures.
The lawsuit claims Hy-Vee’s total losses exceed $5 million. The grocery chain is suing Omnisys for breach of contract and negligent misrepresentation.
Omnisys / XiFin Pharmacy Solutions has yet to file a response to the lawsuit. Calls and emails to the company’s media relations office and its public relations firm were not immediately returned on Tuesday.
On its website, the company says it is dedicated to “empowering healthcare providers to achieve financial strength,” in part through medical billing services and claims management.
YOU MAKE OUR WORK POSSIBLE.
Ver nota original ↗
¿Querés un resumen rápido de esta noticia, hecho por nuestra IA?
